Edition:
United States

Tonix Pharmaceuticals Holding Corp (TNXP.OQ)

TNXP.OQ on NASDAQ Stock Exchange Global Market

0.53USD
14 Nov 2018
Change (% chg)

$-0.01 (-2.45%)
Prev Close
$0.54
Open
$0.55
Day's High
$0.55
Day's Low
$0.48
Volume
127,718
Avg. Vol
166,125
52-wk High
$5.10
52-wk Low
$0.48

Chart for

About

Tonix Pharmaceuticals Holding Corp. is a clinical-stage pharmaceutical company. The Company's drug development programs are directed toward disorders affecting the central nervous system (CNS), and include fibromyalgia (FM), and post-traumatic stress disorder (PTSD). It is focused on developing a portfolio of product candidates,... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $7.70
Shares Outstanding(Mil.): 14.20
Dividend: --
Yield (%): --

Financials

  TNXP.OQ Industry Sector
P/E (TTM): -- 80.78 29.53
EPS (TTM): -2.88 -- --
ROI: -113.16 -0.24 13.00
ROE: -113.21 -3.00 14.69

BRIEF-Tonix Pharmaceuticals Holding Corp Enters Into Sales Agreement With Cowen And Co

* TONIX PHARMACEUTICALS HOLDING CORP SAYS ON MAY 1, CO ENTERED INTO SALES AGREEMENT WITH COWEN AND CO RELATING TO SHARES OF CO'S COMMON STOCK OFFERED

May 17 2018

Earnings vs. Estimates